Increased peripartum mortality associated with maternal subclinical malaria in Mozambique.
HIV
Mozambique
Preeclampsia/eclampsia
Pregnancy
Subclinical malaria
Journal
Malaria journal
ISSN: 1475-2875
Titre abrégé: Malar J
Pays: England
ID NLM: 101139802
Informations de publication
Date de publication:
12 Jun 2023
12 Jun 2023
Historique:
received:
27
01
2023
accepted:
01
06
2023
medline:
14
6
2023
pubmed:
13
6
2023
entrez:
12
6
2023
Statut:
epublish
Résumé
Plasmodium falciparum infection in pregnant women in sub-Saharan Africa is often asymptomatic. As these forms of malaria are often submicroscopic and difficult to diagnose by conventional methods (microscopy and/or rapid diagnostic test), diagnosis requires the use of molecular techniques such as polymerase chain reaction (PCR). This study analyses the prevalence of subclinical malaria and its association with adverse maternal and neonatal outcomes, a topic that has been scarcely evaluated in the literature. A cross-sectional study was conducted using semi-nested multiplex PCR to assess the presence of P. falciparum in placental and peripheral blood of 232 parturient pregnant women at the Hospital Provincial de Tete, Mozambique between March 2017 and May 2019. Multivariate regressions were performed to assess the associations of maternal subclinical malaria with several maternal and neonatal outcomes after controlling for the presence of preeclampsia/eclampsia (PE/E) and HIV infection, as well as for other maternal and pregnancy characteristics. In total, 17.2% (n = 40) of the women studied had positive PCR for P. falciparum (7 in placental blood only, 3 in peripheral blood only). We found a significant association between subclinical malaria and a higher peripartum mortality risk, which persisted after controlling for maternal comorbidity and maternal and pregnancy characteristics (adjusted odds ratio: 3.50 [1.11-10.97]). In addition, PE/E and HIV infections were also significantly associated with several adverse maternal and neonatal outcomes. This study demonstrated the association of subclinical malaria, as well as of PE/E and HIV, in pregnant women with adverse maternal and neonatal outcomes. Therefore, molecular methods may be sensitive tools to identify asymptomatic infections that can reduce the impact on peripartum mortality and their contribution to sustained transmission of the parasite in endemic countries.
Sections du résumé
BACKGROUND
BACKGROUND
Plasmodium falciparum infection in pregnant women in sub-Saharan Africa is often asymptomatic. As these forms of malaria are often submicroscopic and difficult to diagnose by conventional methods (microscopy and/or rapid diagnostic test), diagnosis requires the use of molecular techniques such as polymerase chain reaction (PCR). This study analyses the prevalence of subclinical malaria and its association with adverse maternal and neonatal outcomes, a topic that has been scarcely evaluated in the literature.
METHODS
METHODS
A cross-sectional study was conducted using semi-nested multiplex PCR to assess the presence of P. falciparum in placental and peripheral blood of 232 parturient pregnant women at the Hospital Provincial de Tete, Mozambique between March 2017 and May 2019. Multivariate regressions were performed to assess the associations of maternal subclinical malaria with several maternal and neonatal outcomes after controlling for the presence of preeclampsia/eclampsia (PE/E) and HIV infection, as well as for other maternal and pregnancy characteristics.
RESULTS
RESULTS
In total, 17.2% (n = 40) of the women studied had positive PCR for P. falciparum (7 in placental blood only, 3 in peripheral blood only). We found a significant association between subclinical malaria and a higher peripartum mortality risk, which persisted after controlling for maternal comorbidity and maternal and pregnancy characteristics (adjusted odds ratio: 3.50 [1.11-10.97]). In addition, PE/E and HIV infections were also significantly associated with several adverse maternal and neonatal outcomes.
CONCLUSION
CONCLUSIONS
This study demonstrated the association of subclinical malaria, as well as of PE/E and HIV, in pregnant women with adverse maternal and neonatal outcomes. Therefore, molecular methods may be sensitive tools to identify asymptomatic infections that can reduce the impact on peripartum mortality and their contribution to sustained transmission of the parasite in endemic countries.
Identifiants
pubmed: 37309000
doi: 10.1186/s12936-023-04613-3
pii: 10.1186/s12936-023-04613-3
pmc: PMC10258955
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
182Informations de copyright
© 2023. The Author(s).
Références
Lancet. 2016 Mar 5;387(10022):999-1011
pubmed: 26342729
Front Genet. 2021 Jun 25;12:668574
pubmed: 34249090
Glob Health Sci Pract. 2016 Jun 27;4(2):350-1
pubmed: 27353628
Clin Vaccine Immunol. 2006 May;13(5):568-74
pubmed: 16682478
J Infect Dis. 2019 Jul 2;220(3):457-466
pubmed: 30891605
PLoS One. 2020 Apr 21;15(4):e0231477
pubmed: 32315341
Int J Environ Res Public Health. 2020 Apr 30;17(9):
pubmed: 32365839
Clin Infect Dis. 2015 May 15;60(10):1481-8
pubmed: 25694651
PLoS One. 2018 Feb 2;13(2):e0184249
pubmed: 29394247
Am J Trop Med Hyg. 1995 Jun;52(6):565-8
pubmed: 7611566
PLoS Med. 2006 Nov;3(11):e446
pubmed: 17105340
Am J Trop Med Hyg. 2003 Apr;68(4):503-4
pubmed: 12875305
J Infect Dis. 2009 Nov 15;200(10):1509-17
pubmed: 19848588
Clin Infect Dis. 2020 Jun 24;71(1):166-174
pubmed: 32215629
Front Med (Lausanne). 2022 Dec 08;9:1061538
pubmed: 36569122
Malar J. 2020 Oct 23;19(1):381
pubmed: 33097044
Clin Infect Dis. 2020 Jun 24;71(1):175-176
pubmed: 31404464
Reprod Health. 2016 Sep 30;13(Suppl 2):105
pubmed: 27719683
Curr Hypertens Rep. 2014 Aug;16(8):454
pubmed: 24915961
Malar J. 2011 Sep 07;10:258
pubmed: 21899731
Malar J. 2017 Jan 3;16(1):11
pubmed: 28049536
J Infect Dis. 2020 Aug 4;222(5):863-870
pubmed: 32249917
PLoS One. 2020 Jun 5;15(6):e0233323
pubmed: 32502144
Clin Infect Dis. 2021 Oct 20;73(8):1355-1361
pubmed: 33846719
Sci Rep. 2020 May 19;10(1):8280
pubmed: 32427864
Am J Epidemiol. 2009 Oct 1;170(7):847-53
pubmed: 19679749
PLoS One. 2013 Oct 04;8(10):e74848
pubmed: 24124458
Acta Trop. 2016 Jan;153:111-5
pubmed: 26477849
J Obstet Gynaecol Can. 2012 Feb;34(2):136-141
pubmed: 22340062
PLoS One. 2017 Jun 2;12(6):e0178134
pubmed: 28575010
PLoS Med. 2008 Feb;5(2):e44
pubmed: 18288887